D. Olive

D. Olive, P. Baeuerle, J. Imbert, 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Temporal and Subunit-specific Modulations of the Rel/NF-κB Transcription Factors Through CD28 Costimulation*

D. Olive, P. Lécine, B. Kahn-Perlès, 1997, The Journal of Biological Chemistry.

Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.

D. Olive, J. Soulillou, F. Villemain, 2002, Blood.

Reciprocal Expression of the TNF Family Receptor Herpes Virus Entry Mediator and Its Ligand LIGHT on Activated T Cells: LIGHT Down-Regulates Its Own Receptor1

D. Olive, S. Khandekar, R. Sweet, 2000, The Journal of Immunology.

A unique CD44 monoclonal antibody identifies a new T cell activation pathway

D. Olive, A. Pierrès, C. Mawas, 1992, European journal of immunology.

Primary plasma cell leukaemia: a report of 18 cases.

R. Bouabdallah, D. Olive, A. Delmer, 2001, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients

D. Olive, B. La Scola, J. Mege, 2022, bioRxiv.

Homology Domain Interface Independently of Its Pleckstrin Tec Kinase Migrates to the T Cell-APC Olive

D. Olive, D. Isnardon, G. Bismuth, 2004 .

γ9δ2T cell diversity and the receptor interface with tumor cells.

A. Heck, D. Olive, K. Lidke, 2020, The Journal of clinical investigation.

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma

D. Olive, C. Lebbé, D. Sène, 2016, Oncotarget.

NK Receptors: Tools for a Polyvalent Cell Family

D. Olive, M. López-Botet, S. Sivori, 2014, Front. Immunol..

The co‐expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160‐mediated cytolytic effector function

D. Olive, J. Rey, F. Mallet, 2006, European journal of immunology.

CD28 costimulation promotes an antitumor CD8+ T cell response in myeloid antigen-presenting cell niches

D. Olive, J. Nunès, 2021, Cellular & Molecular Immunology.

Transmembrane signaling via both CD3 and CD2 human T cell surface molecules involves protein kinase-C translocation

D. Olive, J. Nunès, Marc Lopez, 1989, La Ricerca in clinica e in laboratorio.

Cutting Edge: Dok-1 and Dok-2 Adaptor Molecules Are Regulated by Phosphatidylinositol 5-Phosphate Production in T Cells1

D. Olive, J. Nunès, B. Payrastre, 2009, The Journal of Immunology.

The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity1

D. Olive, R. Sweet, R. Costello, 2001, The Journal of Immunology.

Specific CTL Activity of Dendritic Cell Maturation and Elicit CD 154 ( CD 40 Ligand ) Costimulate Induction The TNF Superfamily Members LIGHT and

D. Olive, R. Sweet, R. Costello, 2001 .

The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.

D. Olive, P. Baeuerle, J. Imbert, 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Natural Killer Cell-triggering Receptors in Patients with Acute Leukaemia

D. Olive, C. Fauriat, J. Rey, 2003, Leukemia & lymphoma.

Vγ9Vδ2 TCR‐activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6

D. Olive, C. Scholz, Jianqiang Li, 2014, European journal of immunology.

Author manuscript, published in "European Journal of Immunology 2011;41(12):3443-54" DOI: 10.1002/eji.201141404 Differential role for CD277 as co-regulator of the immune signal in T and NK cells

B. Chetaille, D. Olive, J. Nunès, 2011 .

Adenanthin, a new inhibitor of thiol‐dependent antioxidant enzymes, impairs the effector functions of human natural killer cells

D. Olive, J. Gołąb, C. Fauriat, 2015, Immunology.

Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation

D. Olive, H. Chambost, F. Gondois-Rey, 2013, Bone Marrow Transplantation.

PD-L2 is expressed on activated human T cells and regulates their function.

D. Olive, J. Nunès, S. Pastor, 2011, Molecular immunology.

Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.

D. Olive, P. Balestra, G. Filaci, 2008, Human immunology.

B7/butyrophilin family members are leading the race for immune intervention

D. Olive, 2007 .

Imbalance of Circulating Monocyte Subsets and PD-1 Dysregulation in Q Fever Endocarditis: The Role of IL-10 in PD-1 Modulation

D. Olive, D. Raoult, J. Mege, 2014, PloS one.

Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling

D. Olive, R. Rottapel, J. Nunès, 1994, Nature.

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples.

D. Olive, V. Bardou, G. Monges, 1999, American journal of clinical pathology.

LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell‐dependent B cell terminal differentiation

D. Olive, C. Pasero, F. Mallet, 2004, European journal of immunology.

Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency.

A. Fischer, D. Olive, C. Picard, 2013, The Journal of allergy and clinical immunology.

Tec kinase is involved in transcriptional regulation of IL‐2 and IL‐4 in the CD28 pathway

D. Olive, Wen-Chin Yang, 1999, European journal of immunology.

What is the real role of CD40 in cancer immunotherapy?

D. Olive, R. Costello, J. Gastaut, 1999, Immunology today.

Two distinct TL-like molecular subsets defined by monoclonal antibodies on the surface of human thymocytes with different expression on leukemia lines

D. Olive, P. Dubreuil, C. Mawas, 2004, Immunogenetics.

A soluble form of the human CD8 alpha chain expressed in the baculovirus system: biochemical characterization and binding to MHC class I.

D. Olive, R. Mariuzza, A. Alcover, 1993, Molecular immunology.

Human T cell clones with γδ and αβ receptors are differently stimulated by monoclonal antibodies to CD2

D. Olive, G. Pawelec, H. Bühring, 1990 .

Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.

D. Olive, G. Pantaleo, L. Moretta, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sites.

D. Olive, J. Moreau, H. Gascan, 1987, Human immunology.

Anti‐interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody‐receptor interactions in their antagonist effects on interleukin 2‐dependent T cell growth

D. Olive, D. Charmot, P. Dubreuil, 1986, European journal of immunology.

Human Lymphocyte Functional Antigens

D. Olive, D. Charmot, P. Dubreuil, 1985 .

T Cell Activation Antigens: Kinetics, Tissue Distribution, Molecular Weights, and Functions; Induction on Non T Cell Lines by Lymphokines

D. Olive, D. Charmot, P. Dubreuil, 1985 .

LIGHT, a new TNF superfamily member, is essential for memory T helper cell‐mediated activation of dendritic cells

D. Olive, R. Costello, Y. Morel, 2003, European journal of immunology.

PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphoma.

D. Olive, G. Laurent, C. Laurent, 2007, Blood.

Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis

D. Olive, D. Raoult, B. La Scola, 2021, The Journal of Infectious Diseases.

Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis

D. Olive, D. Raoult, B. Scola, 2020, bioRxiv.

Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein.

D. Olive, J. Peyron, D. Cantrell, 1998, International immunology.

CD28 can promote T cell survival through a phosphatidylinositol 3‐kinase‐independent mechanism

D. Olive, Y. Collette, M. Ghiotto, 1997, European journal of immunology.

Comparison of CD28‐B7.1 and B7.2 functional interaction in resting human T cells: Phosphatidylinositol 3‐kinase association to CD28 and cytokine production

D. Olive, M. Waterfield, M. Ghiotto‐Ragueneau, 1996, European journal of immunology.

CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases.

J. Woodgett, D. Olive, D. Cantrell, 1996, Molecular immunology.

CD28 costimulation regulates long-term expression of the three genes (α, β, γ) encoding the high-affinity IL2 receptor

F. Birg, D. Olive, C. Mawas, 1995 .

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM

D. Olive, J. Leitner, P. Steinberger, 2022, Frontiers in Immunology.

The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.

R. Bouabdallah, L. Xerri, D. Olive, 2013, Blood.

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse.

D. Olive, D. Blaise, J. Reiffers, 1991, Blood.

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies

D. Olive, M. Słabicki, J. Gołąb, 2014, mAbs.

Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study.

D. Olive, H. Chambost, Y. Collette, 2000, Leukemia research.

Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy

D. Olive, L. Gorvel, F. Amatore, 2019, Expert opinion on biological therapy.

Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy

D. Olive, L. Gorvel, F. Amatore, 2018, Expert opinion on therapeutic targets.

B and T Lymphocyte Attenuator Mediates Inhibition of Tumor-Reactive CD8+ T Cells in Patients After Allogeneic Stem Cell Transplantation

D. Olive, A. Korman, H. Dolstra, 2012, The Journal of Immunology.

PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

J. Bussink, D. Olive, J. Cany, 2018, Cancer Immunology Research.

Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols.

D. Olive, C. Fauriat, J. Rey, 2004, The Lancet. Oncology.

The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4(+) T cells.

D. Olive, E. Serfling, C. Cerdan, 2000, Blood.

The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy.

D. Olive, D. Speiser, C. Pasero, 2012, Current opinion in pharmacology.

B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their Function

D. Olive, E. Remmerswaal, R. V. van Lier, 2010, The Journal of Immunology.

Infection and Regulates Their Function Expressed on CMV-Specific T Cells during B and T Lymphocyte Attenuator Is Highly

D. Olive, E. Remmerswaal, I. Hirsch, 2010 .

A role for HVEM, but not lymphotoxin‐β receptor, in LIGHT‐induced tumor cell death and chemokine production

D. Olive, A. Bernard, J. Rey, 2009, European journal of immunology.

Coxiella burnetii Induces Inflammatory Interferon-Like Signature in Plasmacytoid Dendritic Cells: A New Feature of Immune Response in Q Fever

D. Olive, D. Raoult, J. Mege, 2016, Front. Cell. Infect. Microbiol..

HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.

D. Olive, V. Soumelis, J. Nunès, 2012, Blood.

HCV glycoprotein E 2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells

D. Olive, V. Soumelis, J. Nunès, 2012 .

Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma.

D. Olive, M. Mohty, J. Grob, 2010, Immunobiology.

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

D. Olive, S. Vieni, V. Bazan, 2022, Frontiers in Oncology.

Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias

D. Olive, M. Lafage‐Pochitaloff, D. Sainty, 1999, European journal of immunology.

LIGHT Down-Regulates Its Own Receptor Its Ligand LIGHT on Activated T Cells: Receptor Herpes Virus Entry Mediator and Reciprocal Expression of the TNF Family

D. Olive, S. Khandekar, R. Sweet, 2000 .

in T Cells Phosphatidylinositol 5-Phosphate Production Molecules Are Regulated by Cutting Edge: Dok-1 and Dok-2 Adaptor

D. Olive, J. Nunès, B. Payrastre, 2009 .

Rank ligand stimulation induces a partial but functional maturation of human monocyte-derived dendritic cells.

D. Olive, R. Sweet, R. Costello, 2008, European cytokine network.

Regulation of CD80/B7‐1 and CD86/B7‐2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition

D. Olive, F. Mallet, D. Maraninchi, 1998, European journal of immunology.

Reply to Chen and Vitetta.

P. Morange, D. Olive, J. Mege, 2021, The Journal of infectious diseases.

Programmed death ligand-1 expression and memory T-cell generation in Coxiella burnetii infection.

D. Olive, J. Mege, Mignane B. Ka, 2015, Microbial pathogenesis.

Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.

D. Olive, F. Lemonnier, B. Malissen, 1984, Journal of immunology.

Expression of Myeloid and B Cell-Associated Antigens on T Lineage Cells

D. Olive, P. Dubreuil, P. Mannoni, 1986 .

MAGE-A genes are not expressed in human leukemias

D. Olive, F. Brasseur, H. Chambost, 2001, Leukemia.

Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.

F. Birg, D. Olive, C. Mawas, 1992, Journal of immunology.

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells

D. Olive, J. Nunès, P. Dubreuil, 2018, Front. Immunol..

In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation

D. Olive, J. Mege, J. Nunès, 2015, Cellular and Molecular Life Sciences.

Role for the CD28 Molecule in the Control of Coxiella burnetii Infection

D. Olive, D. Raoult, H. Lepidi, 2006, Infection and Immunity.

Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity

D. Olive, J. Guillet, M. Dalod, 1996, Journal of virology.

Signal Transduction by CD28 Costimulatory Receptor on T Cells

D. Olive, D. Cantrell, J. Nunès, 1996, The Journal of Biological Chemistry.

CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells

D. Olive, D. Speiser, E. Mamessier, 2013, Journal of Molecular Medicine.

Transplantationin Patients After Allogeneic Stem Cell T Cells + Inhibition of Tumor-Reactive CD8 B and T Lymphocyte Attenuator Mediates

D. Olive, A. Korman, H. Dolstra, 2012 .

Interaction of Brucella abortusLipopolysaccharide with Major Histocompatibility Complex Class II Molecules in B Lymphocytes

D. Olive, P. Sansonetti, E. Moreno, 1999, Infection and Immunity.

Tec kinases: a family with multiple roles in immunity.

D. Olive, J. Nunès, Y. Collette, 2000, Immunity.

Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling

D. Olive, R. Rottapel, J. Nunès, 1994, Nature.

T cell activation via the CD2 molecule is associated with protein kinase C translocation from the cytosol to the plasma membrane

D. Olive, J. Nunès, A. Pierrès, 1989, European journal of immunology.

Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen‐dependent and antigen‐independent pathways of human T cell activation

D. Olive, G. Pantaleo, L. Moretta, 1986, European journal of immunology.

Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T‐lymphocyte subset in normal and mycosis fungoides skin

D. Olive, L. Michel, M. Bagot, 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis

D. Olive, D. Blaise, V. Leblond, 1995, The Lancet.

Immune System Gene During Emergence of the Adaptive fyn Cutting Edge: Recruitment of the Ancestral

D. Olive, P. Pontarotti, Y. Collette, 2002 .

Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation.

D. Olive, D. Blaise, P. Viens, 1990, Blood.

Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.

D. Olive, P. Debré, A. Vazquez, 1987, Journal of immunology.

Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity

D. Olive, F. Mallet, R. Sweet, 2003, Leukemia.

Erratum to “Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia” [Hum Pathol 2008;39:1050-1058]

L. Xerri, B. Chetaille, D. Olive, 2010 .

CD28 co‐stimulation results in down‐regulation of lymphotactin expression in human CD4+ but not CD8+ T cells via an IL‐2‐dependent mechanism

D. Olive, C. Cerdan, 1999, European journal of immunology.

Major pathways involved in macrophage polarization in cancer

D. Olive, C. Cano, Clément Kerneur, 2022, Frontiers in Immunology.

Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report

D. Olive, D. Blaise, M. Mohty, 2001, Bone Marrow Transplantation.

Role of Tec kinase in nuclear factor of activated T cells signaling.

D. Olive, J. Nunès, R. Castellano, 2000, International immunology.

CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events.

D. Olive, J. Nunès, C. Mawas, 1993, International immunology.

Tumor escape from immune surveillance.

D. Olive, R. Costello, J. Gastaut, 1999, Archivum immunologiae et therapiae experimentalis.

Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia

D. Olive, D. Blaise, M. Mohty, 2002, Leukemia.

Reply to van de Loosdrecht et al

D. Olive, M. Mohty, B. Gaugler, 2003, Leukemia.

Coxiella burnetii Avoids Macrophage Phagocytosis by Interfering with Spatial Distribution of Complement Receptor 31

D. Olive, D. Raoult, J. Mege, 2003, The Journal of Immunology.

Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL.

D. Olive, Y. Collette, A. Benziane, 1998, Blood.

The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response

D. Olive, P. Pontarotti, P. Gouret, 2012, Immunogenetics.

Prevention of graft failure by an anti human leukocyte functional antigen 1 monoclonal antibody in hla mismatched bone marrow transplantation

A. Fischer, D. Olive, C. Griscelli, 1986 .

PREVENTION OF GRAFT FAILURE BY AN ANTI-HLFA-1 MONOCLONAL ANTIBODY IN HLA-MISMATCHED BONE-MARROW TRANSPLANTATION

A. Fischer, F. Deist, D. Olive, 1986, The Lancet.

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation

D. Olive, D. Blaise, M. Mohty, 2005, Leukemia.

Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3

D. Olive, Michael Loran Dustin, T. Springer, 1989, The Journal of experimental medicine.

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells

D. Olive, J. Nunès, S. Létard, 2016, PloS one.

Aggregation and T-Cell Receptor Triggering: A Role for Fas-FasL Distinct Regulation of T-Cell Death by CD28 Depending on Both Its

D. Olive, Y. Collette, A. Benziane, 2013 .

PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua

D. Olive, E. Fulcheri, E. Munari, 2019, Mucosal Immunology.

PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2

D. Olive, J. Soulillou, M. Delaage, 1987, The Lancet.

Expression of T Cell-Related Antigens on Cells from the Myelo-Monocytic Lineage

D. Olive, P. Dubreuil, P. Mannoni, 1986 .

Tec Kinase Migrates to the T Cell-APC Interface Independently of Its Pleckstrin Homology Domain1

D. Olive, D. Isnardon, G. Bismuth, 2004, The Journal of Immunology.

The SH3 domain of Tec kinase is essential for its targeting to activated CD28 costimulatory molecule

D. Olive, J. Nunès, A. Gérard, 2004, European journal of immunology.

Tolerance and Biological Activity of Bolus Administration of Increasing Doses of Glycosylated Recombinant Interleukin-2 (SR 29009) in Patients with Hematological Malignancy

D. Olive, D. Blaise, P. Viens, 1992 .

T-cell: section report.

D. Olive, A. Bensussan, 2005, Cellular immunology.

Evidences for ubiquitination and intracellular trafficking of LAT, the linker of activated T cells.

D. Olive, A. Restouin, Y. Collette, 2005, Biochimica et biophysica acta.

Blood dendritic cells in patients with acute lymphoblastic leukaemia

D. Olive, M. Mohty, H. Chambost, 2004, British journal of haematology.

[The role of co-inhibitory signals driven by CTLA-4 in immune system].

L. Xerri, D. Olive, J. Nunès, 2011, Medecine sciences : M/S.

Expression of activating receptors on natural killer cells from AIDS-related lymphoma patients

K. Baumstarck, D. Olive, N. Mounier, 2014, AIDS Research and Therapy.

Natural killer cells in leukaemia

D. Olive, C. Fauriat, J. Rey, 2010 .

Non-receptor protein tyrosine kinases as immune targets of viruses.

D. Olive, Y. Collette, 1997, Immunology today.

Functional expression of human CD28 in murine T cell hybridomas.

D. Olive, J. Nunès, C. Mawas, 1994, Molecular immunology.

Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation.

D. Olive, J. Nunès, A. Pierrès, 1989, Cellular immunology.

Triggering CD 28 molecules synergize with CD 2 (T11.1 and T11,2)‐mediated T cell activation

D. Olive, J. Nunès, A. Pierrès, 1988, European journal of immunology.

NK cells: innate immunity against hematological malignancies?

D. Olive, C. Fauriat, S. Sivori, 2004, Trends in immunology.

Anti-GM-CSF monoclonal antibody therapy for refractory acute leukemia.

R. Bouabdallah, D. Olive, D. Maraninchi, 1998, Leukemia & lymphoma.

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

D. Olive, B. Malissen, J. Nunès, 2022, bioRxiv.

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation

D. Olive, C. Fauriat, J. Gertner-dardenne, 2013, Oncoimmunology.

Costimulatory Molecules and Autoimmune Thyroid Diseases

D. Olive, C. Salmaso, G. Pesce, 2002, Autoimmunity.

CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells

D. Olive, D. Speiser, E. Mamessier, 2013, Journal of Molecular Medicine.

For Peer Review 1 PD-L 1 and PD-L 2 differ in their molecular mechanisms of interaction with PD-1

D. Olive, J. Nunès, L. Gauthier, 2018 .

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy

D. Olive, A. Chretien, A. Gonçalves, 2022, Seminars in Immunopathology.

The Role of p 21 ~ in CD 28 Signal Transduction : Triggering of CD 28 with Antibodies , but Not the Ligand B 7-1 , Activates p 21

D. Olive, Y. Collette, A. Truneh, 2003 .

Treatment of Relapsed Acute Leukemias with Systemic Recombinant Interleukin 2 (RU 49637)

D. Olive, D. Blaise, P. Viens, 1992 .

Sequential Bolus Administration of rIL-2 (RU 49637) in Treatment of Advanced Solid Malignancies

D. Olive, J. Gabert, D. Blaise, 1990 .

Recovery of Lymphocyte and Dendritic Cell Subsets Following Reduced Intensity Allogeneic Bone Marrow Transplantation

R. Bouabdallah, D. Olive, D. Blaise, 2002, Hematology.

Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.

D. Olive, S. Emiliani, M. Benkirane, 1993, Journal of immunology.

The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle.

D. Olive, Y. Collette, 1999, Virology.

Evidence for intact CD28 signaling in T cell hyporesponsiveness induced by the HIV‐1 nef gene

D. Olive, Y. Collette, C. Mawas, 1996, European journal of immunology.

Role of ICAM-3 in the initial interaction of T lymphocytes and APCs

D. Olive, F. Sánchez‐Madrid, A. Alcover, 2002, Nature Immunology.

Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III–IV acute graft-versus-host disease

D. Olive, D. Blaise, J. Reiffers, 1991 .

Anti‐LFA1 monoclonal antibody (25.3) for treatment of steroid‐resistant grade III‐IV acute graft‐versus‐host disease

D. Olive, D. Blaise, J. Reiffers, 1991, Transplant international : official journal of the European Society for Organ Transplantation.

Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy

R. Bouabdallah, D. Olive, D. Coso, 2012, Journal of Clinical Immunology.

"CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.

D. Olive, A. Pierrès, C. Mawas, 1990, Journal of immunology.

Long Lasting Alteration of Natural Killer Cells Post-Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML).

D. Olive, F. Orlanducci, J. Rey, 2009 .

Pilot study of immunotherapy with interleukin-2 after autologous stem cell transplantation in advanced breast cancers.

D. Olive, D. Blaise, P. Viens, 2000, Anticancer research.

Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.

R. Bouabdallah, D. Olive, D. Blaise, 1997, European cytokine network.

Use of Recombinant Interleukin-2 (RU 49637) After Autologous Bone Marrow Transplantation in Patients with Hematological Disease: Phase I–II Study

D. Olive, D. Blaise, J. Reiffers, 1992 .

Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF)

D. Olive, M. Auffredou, A. Vazquez, 1986, European journal of immunology.

Cellular localization of class I (HLA‐A, B, C) and class II (HLA‐DR and DQ) MHC antigens on the epithelial cells of normal human jejunum

J. Sarles, D. Olive, J. Gorvel, 1984, Biology of the cell.

Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.

S. Granjeaud, D. Olive, D. Blaise, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Macrophages and γδ T cells interplay during SARS-CoV-2 variants infection

D. Olive, B. La Scola, J. Mege, 2022, Frontiers in Immunology.

When breast cancer cells start to fend the educational process of NK cells off

D. Olive, E. Mamessier, C. Bourgin, 2013, Oncoimmunology.

IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.

D. Olive, D. Métivier, O. Lantz, 1989, Journal of immunology.

Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.

D. Olive, F. Mallet, C. Mawas, 1993, Immunology.

Blood dendritic cells in patients with chronic lymphocytic leukaemia.

D. Olive, M. Mohty, B. Gaugler, 2008, Immunobiology.

A Novel Tumor-Associated Pancreatic Glycoprotein Is Internalized by Human Dendritic Cells and Induces Their Maturation

D. Olive, D. Isnardon, E. Béraud, 2011, The Journal of Immunology.

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.

R. Bouabdallah, D. Olive, D. Blaise, 2005, Blood.

IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

D. Olive, M. Mohty, D. Isnardon, 2003, Journal of immunology.

All‐trans retinoic acid skews monocyte differentiationinto interleukin‐12‐secreting dendritic‐like cells

D. Olive, M. Mohty, D. Isnardon, 2003, British journal of haematology.

Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38– primitive haematopoietic progenitors

D. Olive, D. Blaise, M. Mohty, 2002, British journal of haematology.

Analysis of cytosolic ionized calcium variation in polymorphonuclear leukocytes using flow cytometry and Indo-1 AM.

D. Olive, P. Mannoni, M. Lopez, 1989, Cytometry.

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

D. Olive, A. Moretta, M. Parodi, 2016, Journal of immunology research.

CpG Methylation Controls Reactivation of HIV from Latency

C. Van Lint, D. Olive, E. Verdin, 2009, PLoS pathogens.

CpG methylation controls reactivation of HIV from latency

C. Van Lint, D. Olive, E. Verdin, 2010, Retrovirology.

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

D. Olive, D. Blaise, M. Mohty, 2003, Leukemia.

Enediynes bearing polyfluoroaryl sulfoxide as new antiproliferative agents with dual targeting of microtubules and DNA.

D. Olive, F. Dumur, D. Gigmes, 2018, European journal of medicinal chemistry.

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

E. Adams, D. Olive, M. Bonneville, 2012, Blood.

Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts

D. Olive, N. Vey, R. Castellano, 2012, The Journal of Immunology.

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

J. Blay, D. Olive, I. Treilleux, 2009, Cancer research.

CD277 an Immune Regulator of T Cell Function and Tumor Cell Recognition

D. Olive, M. Bonneville, P. Pontarotti, 2011 .

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

D. Olive, A. Moretta, S. Sivori, 2002, Blood.

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

F. Bertucci, D. Birnbaum, D. Olive, 2011, The Journal of clinical investigation.

Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice

D. Olive, G. Marodon, S. Brunel, 2021, Cancers.

HVEM is a Novel Immune Checkpoint for Prostate Cancer Immunotherapy in Humanized Mice

D. Olive, G. Marodon, S. Brunel, 2021 .

TNFRSF14 (HVEM) is a novel immune checkpoint blockade that can be targeted by a monoclonal antibody to improve anti-tumor response in humanized mice

D. Olive, G. Marodon, S. Brunel, 2020 .

HVEM blockade initiates tumor cell death by innate immunity and improves anti-tumor response by human T cells in NSG immuno-compromised mice

D. Olive, G. Marodon, S. Brunel, 2019, bioRxiv.

TNFRSF14 (HVEM) is a novel immune checkpoint for cancer immunotherapy in humanized mice

D. Olive, G. Marodon, S. Brunel, 2019 .

[Detection and quantification of human papillomavirus genital infections: virological, epidemiological, and clinical applications].

D. Olive, C. Tamalet, M. Henry, 2011, Medecine et maladies infectieuses.

Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing

D. Olive, D. Ouzan, A. Raimondo, 2013, PloS one.

Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1 Nef Proteins Show Distinct Patterns and Mechanisms of Src Kinase Activation

Daniel Olive, Karen N. Allen, D. Olive, 1999, Journal of Virology.

Physical and Functional Interaction of Nef with Lck

D. Olive, R. Benarous, F. Ramos-Morales, 1996, The Journal of Biological Chemistry.

Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages

Alain Bernard, Daniel Olive, D. Olive, 2008, European journal of immunology.

Constitutive AKT activation in follicular lymphoma

R. Bouabdallah, L. Xerri, D. Olive, 2014, BMC Cancer.

Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells.

D. Olive, A. Rabellino, G. Pesce, 2010, Molecular immunology.

A co-evolution perspective of the TNFSF and TNFRSF families in the immune system.

André Gilles, Pierre Pontarotti, Daniel Olive, 2003, Trends in immunology.

ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy.

D. Olive, C. Richon, B. Janji, 2014, Cancer research.

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

D. Olive, E. Garon, B. Chanez, 2020, Frontiers in Immunology.

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades

D. Olive, A. Badou, S. Sahraoui, 2021, Frontiers in Immunology.

Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

L. Xerri, B. Chetaille, D. Olive, 2008, Human pathology.

Imatinib: the narrow line between immune tolerance and activation.

D. Olive, D. Blaise, M. Mohty, 2005, Trends in molecular medicine.

DOK1 and DOK2 regulate CD8+ T cell signaling and memory formation without affecting tumor cell killing

D. Olive, J. Nunès, Y. Yamanashi, 2021, bioRxiv.

Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway

D. Olive, P. Secchiero, S. Capitani, 1999 .

Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD 4 1 T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD 95 / CD 95 Ligand Pathway

D. Olive, P. Secchiero, S. Capitani, 1999 .

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

F. Bertucci, D. Birnbaum, P. Finetti, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.

Patrice Ravel, Ludger Johannes, Patrick Bruneval, 2013, Cancer research.

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma

S. Granjeaud, D. Olive, E. Tartour, 2019, Oncoimmunology.

Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies.

D. Olive, P. Viens, J. Pasquier, 1993, Acta endocrinologica.

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity

D. Olive, C. Pasero, A. Benyamine, 2018, Frontiers in Immunology.

Structure, biosynthesis, and transduction properties of the human mu-psi L complex: similar behavior of preB and intermediate preB-B cells in transducing ability.

D. Olive, J. Salamero, C. Schiff, 1993, International immunology.

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

D. Olive, N. Huntington, J. Nunès, 2021, Journal for ImmunoTherapy of Cancer.

Interaction with simian Hck tyrosine kinase reveals convergent evolution of the Nef protein from simian and human immunodeficiency viruses despite differential molecular surface usage.

D. Olive, A. Greenway, G. Holloway, 2002, Virology.

PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.

D. Olive, J. Nunès, L. Gauthier, 2010, International immunology.

The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif Protein*

D. Olive, E. Decroly, R. Vigne, 2001, The Journal of Biological Chemistry.

CTLA-4 and PD-1 : from cloning to therapeutic antibodies

D. Olive, P. Golstein, 2017 .

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

K. Tarte, H. Kohrt, R. Houot, 2016, Oncoimmunology.

Two Distinct Intracytoplasmic Regions of the T-cell Adhesion Molecule CD28 Participate in Phosphatidylinositol 3-Kinase Association (*)

D. Olive, S. Ward, R. Sweet, 1996, The Journal of Biological Chemistry.

PI 3-kinase: a pivotal pathway in T-cell activation?

D. Olive, C. June, S. Ward, 1996, Immunology today.

The Role of Tec Protein-tyrosine Kinase in T Cell Signaling*

D. Olive, M. Ghiotto, Wen-Chin Yang, 1999, The Journal of Biological Chemistry.

A tumour‐associated antigen expression in human haematological malignancies

D. Olive, P. Coulie, F. Brasseur, 1993, British journal of haematology.

Tolerance and feasibility of perioperative treatment with interferon-alpha 2a in advanced cancers.

J. Blache, D. Olive, G. Monges, 1997, International surgery.

The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.

D. Olive, Y. Collette, H. Dutartre, 1998, Virology.

The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck.

D. Olive, Y. Collette, H. Dutartre, 1997, Research in virology.

The CD2 and CD28 adhesion molecules induce long‐term autocrine proliferation of CD4+ T cells

D. Olive, R. Costello, C. Mawas, 1993, European journal of immunology.

Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation.

D. Olive, L. Gorvel, 2022, Seminars in immunology.

Anti-Leukemia Activity of MS-275 Histone Deacetylase Inhibitor Implicates 4-1BBL/4-1BB Immunomodulatory Functions

C. Van Lint, D. Olive, A. Restouin, 2009, PloS one.

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment

Jérôme Galon, Daniel Olive, Juan Iovanna, 2018, Front. Immunol..

Local Ablative Therapy Associated with Immunotherapy in Locally Advanced Pancreatic Cancer: A Solution to Overcome the Double Trouble?—A Comprehensive Review

D. Olive, A. Chretien, J. Garnier, 2022, Journal of clinical medicine.

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

M. Ziol, D. Olive, V. Bourcier, 2019, Oncoimmunology.

Expression of intercellular adhesion molecule‐1 (ICAM‐1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer

G. Canonica, D. Olive, C. Betterle, 1991, Clinical and experimental immunology.

A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage

D. Olive, C. Caux, A. Morel, 2015, Oncoimmunology.

Abundant expression of fibronectin is a major feature of leukemic dendritic cells differentiated from patients with acute myeloid leukemia

D. Olive, M. Mohty, D. Isnardon, 2004, Leukemia.

Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.

F. Bertucci, D. Birnbaum, P. Finetti, 2011, Cancer research.

Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?

D. Olive, A. Russo, F. Fulfaro, 2019, Therapeutic advances in medical oncology.

Altered splicing in hematological malignancies reveals a tissue-specific translational block of the Src-family tyrosine kinase fyn brain isoform expression

D. Olive, Y. Collette, C. Picard, 2004, Leukemia.

Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure

Ronan Boulmé, Dimitri Gonzalez, Daniel Olive, 2014, AIDS (London).

Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis

D. Olive, D. Blaise, M. Mohty, 2002, Leukemia.

[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].

D. Olive, D. Blaise, M. Mohty, 2003, Bulletin du Cancer.

[Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].

D. Olive, B. Gaugler, 1998, Pathologie et biologie.

Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).

D. Olive, D. Blaise, J. Reiffers, 1991, Bone marrow transplantation.

Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.

D. Olive, J. Gabert, D. Blaise, 1991, Bone marrow transplantation.

CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.

D. Olive, D. Blaise, M. Mohty, 2004, Experimental hematology.

CD molecules 2005: human cell differentiation molecules.

Karel Drbal, Laurence Boumsell, Pablo Engel, 2005, Blood.

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity

J. Rossi, D. Olive, C. Pasero, 2016, PloS one.

Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV‐1 infected patients

D. Olive, P. Halfon, H. Khiri, 2014, Journal of medical virology.

Role of Vγ9vδ2 T lymphocytes in infectious diseases

D. Olive, J. Mege, C. Cano, 2022, Frontiers in immunology.

Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization

D. Olive, G. Tabellini, L. Moretta, 2017, The Journal of allergy and clinical immunology.

miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells

J. Bourhis, D. Olive, P. Dessen, 2015, Oncoimmunology.

Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase

D. Olive, J. Nunès, Y. Collette, 2004, Oncogene.

687 Enhancement of anti-tumor immunity by ICT01: a novel g9d2 T cell-activating antibody targeting butyrophilin-3A (BTN3A)

S. Agaugué, D. Olive, R. Hoet, 2020, Journal for ImmunoTherapy of Cancer.

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

D. Olive, L. Gorvel, C. Demerle, 2021, Frontiers in Oncology.

CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.

Ornella Pagliano, J. Kirkwood, H. Zarour, 2012, Cancer research.

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.

D. Olive, D. Speiser, P. Romero, 2010, The Journal of clinical investigation.

Subcellular Localization of Class I (A,B,C) and Class II (DR and DQ) MHC Antigens in Jejunal Epithelium of Children with Coeliac Disease

J. Sarles, D. Olive, J. Gorvel, 1987, Journal of pediatric gastroenterology and nutrition.

B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease.

A M Riccio, D. Olive, A. Riccio, 1998, The Journal of clinical endocrinology and metabolism.

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

S. Granjeaud, D. Olive, N. Salem, 2016, Cancer research.

Anti‐HLA antigen class I heavy chain monoclonal antibodies inhibit human immunodeficiency virus production by peripheral blood mononuclear cells

D. Olive, C. Devaux, P. Corbeau, 1991, European journal of immunology.

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

S. Granjeaud, D. Olive, A. Toubert, 2017, Front. Immunol..

Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.

D. Olive, C. Arnoulet, F. Mallet, 2000, Cancer research.

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.

Christophe Caux, Uzma Hasan, Daniel Olive, 2010, Trends in immunology.

A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system

D. Olive, C. Caux, R. Ramos, 2018, bioRxiv.

Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells

D. Olive, P. Pontarotti, Y. Collette, 2004, European journal of immunology.

Hepatitis C Virus Fails To Activate NF-κB Signaling in Plasmacytoid Dendritic Cells

D. Olive, J. Nunès, I. Hirsch, 2011, Journal of Virology.

A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system

D. Olive, C. Caux, R. Ramos, 2019, Oncoimmunology.

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology

D. Olive, A. Chretien, E. Lambaudie, 2021, Biomedicines.

High expression of indoleamine 2,3‐dioxygenase in the tumour is associated with medullary features and favourable outcome in basal‐like breast carcinoma

F. Bertucci, D. Birnbaum, L. Xerri, 2012, International journal of cancer.

Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients.

G. Salles, R. Bouabdallah, L. Xerri, 2017, Human pathology.

Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.

G. Salles, L. Xerri, F. Morschhauser, 2014, Human pathology.

Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor antibodies.

M. Ferrer, D. Olive, A. Dautry‐Varsat, 1991, The Journal of biological chemistry.

Active Transcription of the Human FASL/CD95L/TNFSF6 Promoter Region in T Lymphocytes Involves Chromatin Remodeling

C. Van Lint, D. Olive, I. Hirsch, 2006, Journal of Biological Chemistry.

Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses

D. Olive, D. Speiser, V. Zoete, 2017, PloS one.

OM-197-MP-AC adjuvant properties: the in vitro maturation of normal and leukemic dendritic cells in a serum-free culture model.

D. Olive, M. Mohty, B. Gaugler, 2004, Immunobiology.

Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4

D. Olive, P. Coulie, D. Colau, 2016, Cancer Immunology, Immunotherapy.

1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.

C. Pannecouque, D. Olive, C. Bailly, 2000, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Means to induce or enhance the immunogenicity of acute myeloid leukemias cells

D. Olive, A. Charbonnier, 1999 .

The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38− leukemic progenitors

D. Olive, H. Chambost, C. Arnoulet, 1999, Leukemia.

IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways.

F. Birg, D. Olive, C. Mawas, 1991, Journal of immunology.

Interleukin-7, a major T-lymphocyte cytokine.

D. Olive, J. Imbert, R. Costello, 1993, European cytokine network.

A granulocytic signature identifies COVID-19 and its severity

P. Morange, D. Olive, J. Mege, 2020, The Journal of infectious diseases.

Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer

D. Olive, J. Nunès, C. Fauriat, 2019, Front. Immunol..

Comparison of blocking effects of monoclonal antibodies anti-MO1-alpha and anti-LFA1-alpha on human neutrophil functions.

D. Olive, P. Debré, M. Gougerot-Pocidalo, 1987, Immunology.

Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer

D. Olive, E. Béraud, D. Lombardo, 2012, Oncoimmunology.

Imbalance of circulating lymphoid cells in Q fever endocarditis.

D. Olive, D. Raoult, J. Mege, 2015, Pathogens and disease.

Plasmacytoid DCs and cancer: a new role for an enigmatic cell.

D. Olive, M. Mohty, B. Gaugler, 2004, Trends in immunology.

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor.

E. Adams, D. Olive, G. Schuurhuis, 2016, Cell reports.

T lymphocyte subsets in cancer immunity: Friends or foes

D. Olive, A. Badou, A. Naim, 2018, Journal of leukocyte biology.

Microenvironment and Immunology CD 8 þ T Cells Speci fi c for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

Ornella Pagliano, J. Kirkwood, H. Zarour, 2012 .

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

C. Porta, D. Olive, A. Russo, 2020, Oncoimmunology.

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma

D. Olive, A. Russo, J. Iovanna, 2019, Oncoimmunology.

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

D. Olive, J. Dagorn, J. Iovanna, 2018, Oncoimmunology.

Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen

D. Olive, D. Blaise, M. Mohty, 2004, Bone Marrow Transplantation.

Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia

D. Olive, Y. Kerdiles, G. Bidaut, 2021, Frontiers in Immunology.

Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33–q34

D. Olive, R. Costello, P. Mannoni, 2004, Immunogenetics.

Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors

D. Olive, M. Gilabert, S. Taix, 2018, Front. Immunol..

Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2.

D. Olive, J. Moreau, J. Soulillou, 1986, Journal of immunology.

The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response

D. Olive, P. Pontarotti, P. Gouret, 2012, Immunogenetics.

The molecular basis for modulation of human V(gamma)9V(delta)2 T cell response by CD277/Butryophilin (BTN3A)-specific antibodies

E. Adams, D. Olive, M. Bonneville, 2012 .

Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response

S. Agaugué, D. Olive, R. Hoet, 2021, Science Translational Medicine.

Selection of tumor-resistant variants following sustained natural killer cell-mediated immune stress

S. Terry, D. Olive, B. Janji, 2020, Oncology reports.

A gene expressed exclusively in acute B lymphoblastic leukemias.

D. Olive, P. Coulie, L. Michaux, 2004, Genomics.

Role of the LFA3-CD2 interaction in human specific B cell differentiation.

D. Olive, P. Galanaud, D. Émilie, 1988, Journal of immunology.

Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation

T. Pozzan, D. Olive, G. Pantaleo, 1987, The Journal of experimental medicine.

In vivo regulation of interleukin‐2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells.

D. Olive, P. Lécine, A. Plet, 1995, The EMBO journal.

The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission.

D. Olive, D. Blaise, J. Reiffers, 1997, Leukemia & lymphoma.

Interleukin‐2 in Association with Increasing Doses of Interferon‐Gamma in Patients with Advanced Cancer

D. Olive, D. Blaise, C. Bressac, 1992, Journal of immunotherapy.

Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade.

L. Xerri, D. Olive, E. Tartour, 2021, Blood advances.

Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity.

D. Olive, C. Pasero, 2013, Immunology letters.

Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.

D. Olive, M. Hurle, R. Sweet, 1996, Molecular immunology.

Increased T-Cell Activation and Th1 Cytokine Concentrations Prior to the Diagnosis of B-Cell Lymphoma in HIV Infected Patients

D. Olive, N. Nagot, V. Foulongne, 2012, Journal of Clinical Immunology.

Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC

D. Olive, P. Validire, S. Katsahian, 2022, Communications biology.

The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.

M. Goldsmith, D. Olive, Michael Loran Dustin, 1988, Journal of immunology.

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia

D. Olive, F. Orlanducci, A. Le Roy, 2016, Oncoimmunology.

Interleukin-2 (IL-2) After Autologous Bone Marrow Transplantation (BMT):A Pilot Study of Late Administration, 2–3 Months Post ABMT

D. Olive, D. Blaise, C. Jasmin, 1990 .

New Microbicidal Functions of Tracheal Glands: Defective Anti-Infectious Response to Pseudomonas aeruginosa in Cystic Fibrosis

D. Olive, J. Mege, S. de Bentzmann, 2009, PloS one.

A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.

R. Bouabdallah, D. Olive, D. Blaise, 1998, Leukemia & lymphoma.

Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity

D. Olive, J. Imbert, T. Treut, 2010, Cancer Immunology, Immunotherapy.

Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study

D. Olive, D. Blaise, A. Chretien, 2021, Blood.

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

S. Granjeaud, D. Olive, D. Blaise, 2021, Proceedings of the National Academy of Sciences.

High-dimensional mass cytometry analysis of NK cell alterations in Acute Myeloid Leukemia identifies a subgroup with adverse clinical outcome

S. Granjeaud, D. Olive, D. Blaise, 2020, medRxiv.

Granular lymphoproliferative disorder, autologous blood stem cell transplantation and multiple myeloma

D. Olive, J. Rey, R. Costello, 2003, European journal of haematology.

T-Cell Functional Evaluation Following Bone Marrow Transplantation

D. Olive, D. Charmot, D. Maraninchi, 1985 .

Expression of gene MAGE-A4 in Reed-Sternberg cells.

L. Xerri, D. Olive, P. Coulie, 2000, Blood.

Current update on reduced intensity regimens for allogeneic stem cell transplantation

D. Olive, D. Blaise, M. Mohty, 2005, Hematology.

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

D. Olive, D. Blaise, R. Devillier, 2020, Cancers.

Generation of leukemic dendritic cells from patients with acute myeloid leukemia.

D. Olive, M. Mohty, B. Gaugler, 2003, Methods in molecular biology.

Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells

D. Olive, C. Fauriat, F. Orlanducci, 2017, Front. Immunol..

Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.

R. Bouabdallah, S. Granjeaud, L. Xerri, 2016, Cancer research.

Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells

D. Olive, L. Moretta, C. Romagnani, 2001, Proceedings of the National Academy of Sciences of the United States of America.

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells.

P. Gaulard, R. Bouabdallah, D. Olive, 2020, Blood advances.

Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide

D. Olive, D. Blaise, M. Mohty, 2002, Journal of leukocyte biology.

Analysis of CD28 Interactions with Its Cognate Counter-Receptors CD80 and CD86

D. Olive, I. Kariv, M. Hurle, 1996 .

Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets

F. Bertucci, D. Birnbaum, D. Olive, 2013, The Journal of Immunology.

The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies*

Marc Bonneville, Daniel Olive, Emmanuel Scotet, 2012, The Journal of Biological Chemistry.

Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.

Hai-Tao He, Hervé Rigneault, Yannick Hamon, 2008, Nature chemical biology.

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

S. Granjeaud, D. Olive, N. Salem, 2015, Oncotarget.

Targeting EGFR and HER2 for Molecular Imaging of Cancer

D. Olive, Lakshmi Sampath, J. Kovar, 2012 .

NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27

D. Olive, A. Vacca, A. Moretta, 2017, Oncotarget.

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM‐1) during chronic viraemic HCV infection is associated with the outcome of combined treatment

D. Olive, I. Hirsch, L. Moretta, 2011, European journal of immunology.

Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma

R. Bouabdallah, B. Chetaille, B. Esterni, 2014, Leukemia & lymphoma.

Mechanisms Regulating Expression of the Tumor Necrosis Factor-related light Gene

C. Van Lint, D. Olive, R. Castellano, 2002, The Journal of Biological Chemistry.

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

P. Parham, D. Olive, P. Norman, 2017, The Journal of experimental medicine.

Evaluation of type‐specific HPV persistence and high‐risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology

D. Olive, W. Prendiville, C. Tamalet, 2011, Journal of medical virology.

CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas.

K. Tarte, R. Bouabdallah, S. Granjeaud, 2018, Blood advances.

Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1

D. Olive, I. Hirsch, T. Baumert, 2009, PloS one.

Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy

D. Olive, D. Blaise, R. Devillier, 2020, Journal of leukocyte biology.

Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants

D. Olive, C. Bailly, E. Meurs, 1999, The Journal of Biological Chemistry.

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.

D. Olive, R. Hoet, C. Cano, 2021, Cell reports.

Butyrophilin 3A (BTN3A, CD277)‐specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation

D. Olive, Jianqiang Li, G. De Libero, 2017, European journal of immunology.

PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua

D. Olive, E. Fulcheri, E. Munari, 2019, Mucosal Immunology.

Novel CD28-Responsive Enhancer Activated by CREB/ATF and AP-1 Families in the Human Interleukin-2 Receptor α-Chain Locus

D. Olive, S. Spicuglia, P. Lécine, 2001, Molecular and Cellular Biology.

Microenvironment and Immunology Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG 2 D-Mediated and DNAM-Mediated NK Cell Recognition

F. Bertucci, D. Birnbaum, P. Finetti, 2011 .

Hepatitis C virus fails to activate NF-kappaB signaling in plasmacytoid dendritic cells

D. Olive, J. Nunès, I. Hirsch, 2012, Retrovirology.

Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitment

D. Olive, F. Sánchez‐Madrid, C. Langlet, 2004, Journal of Cell Science.

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

S. Granjeaud, D. Olive, A. Cerwenka, 2017, Oncotarget.

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities

S. Granjeaud, D. Olive, J. Mege, 2018, Front. Immunol..

Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function

D. Olive, A. Savina, E. Lambaudie, 2019, Front. Immunol..

AML drug resistance: c-Myc comes into play.

D. Olive, C. Fauriat, 2014, Blood.

Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 study.

D. Olive, D. Blaise, J. Reiffers, 1991, Bone marrow transplantation.

Butyrophilin 3A/CD277–Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations

D. Olive, O. Janssen, H. Oberg, 2016, The Journal of Immunology.

Targeting the “PVR–TIGIT axis” with immune checkpoint therapies

D. Olive, L. Gorvel, 2020, F1000Research.

PKC –mTOR pathway: a new target for rituximab therapy in follicular lymphoma

D. Olive, G. Laurent, C. Laurent, 2007 .

Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy

D. Olive, C. Tamalet, J. Mancini, 2012, Journal of medical virology.

Randomized Phase 2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial

H. Dombret, D. Olive, S. Leprêtre, 2017 .

Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.

D. Olive, C. Pasero, A. Truneh, 2009, Current molecular medicine.

Two years outcome of women infected with high risk HPV having normal colposcopy following low‐grade or equivocal cytological abnormalities: Are HPV16 and 18 viral load clinically useful predictive markers?

D. Olive, C. Tamalet, J. Mancini, 2012, Journal of medical virology.

Rationale for the utilization of interleukin-4, an immune-recognition induced cytokine, in cancer immunotherapy.

D. Olive, R. Costello, C. Lipcey, 2015, European Journal of Medicine.

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion

F. Bertucci, S. Granjeaud, D. Olive, 2021, Cancers.

Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.

D. Olive, P. Secchiero, S. Capitani, 1999, Blood.

“Stealth” tumors

F. Bertucci, D. Birnbaum, D. Olive, 2012, Oncoimmunology.

Hepatitis C virus fails to activate NF-kappaB signaling in plasmacytoid dendritic cells

D. Olive, J. Nunès, I. Hirsch, 2012, Retrovirology.

Activated but not resting T cells or thymocytes express colony‐stimulating factor 1 mRNA without co‐expressing c‐fms mRNA

F. Birg, D. Olive, A. Pierrès, 1990, European journal of immunology.

Absence of cell surface fixation of a monoclonal antibody detectable by conventional immunoassays does not exclude expression of and interaction with the corresponding antigenic determinant

D. Olive, F. Lemonnier, B. Jordan, 1984, European journal of immunology.

Are CD4 antibodies and peptide T new treatments for psoriasis?

D. Olive, C. Dhiver, I. Poizot-Martin, 1991, The Lancet.

HIV-2 and SIV Nef Proteins Target Different Src Family SH3 Domains than Does HIV-1 Nef because of a Triple Amino Acid Substitution*

D. Olive, S. Arold, R. Benarous, 2000, The Journal of Biological Chemistry.

Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies

D. Olive, S. Scaglione, S. Regis, 2019, Front. Immunol..

Pilot phase I study using zidovudine in association with a 10‐day course of anti‐CD4 monoclonal antibody in seven AIDS patients

D. Olive, C. Dhiver, C. Tamalet, 1989, AIDS.

Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.

D. Olive, D. Charmot, D. Maraninchi, 1987, Bone marrow transplantation.

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma

D. Olive, G. Pignot, J. Walz, 2021, Frontiers in Immunology.

Signal transducing mechanisms involved in human T cell activation via surface T44 molecules. Comparison with signals transduced via the T cell receptor complex

D. Olive, G. Pantaleo, L. Moretta, 1986, European journal of immunology.

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

D. Olive, P. Halfon, G. Pénaranda, 2014, BMC Infectious Diseases.

Composite Subsets Cancer Patients Are Tumor-Induced Peripheral Blood NK Cells from Breast

F. Bertucci, D. Birnbaum, D. Olive, 2013 .

Rapid induction of cytolytic T cells via CD28 stimulation for cellular immunotherapy.

D. Olive, S. Blum, J. Cerottini, 1994, Therapeutic immunology.

Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia.

Daniel Isnardon, Daniel Olive, D. Olive, 2004, Blood.

HVEM: A novel cosignaling molecule of major interest in melanoma.

S. Granjeaud, D. Olive, E. Tartour, 2017 .

Diffuse Large B Cell Lymphoma (DLBCL) infiltrating T Cells Display an Activated and Exhausted Status and Are Inhibited By Ligands of Cosignaling Receptors Including PD-L1, PD-L2 and CD80 Expressed By Most DLBCL in Situ

R. Bouabdallah, L. Xerri, D. Olive, 2014 .

Targeting BTN2A1 enhances Vγ9Vδ2 T cell effector functions and triggers tumor cells pyroptosis

D. Olive, C. Cano, F. Orlanducci, 2023, bioRxiv.

Immunotherapy of acute myeloid leukemia based on γδ T cells

D. Olive, C. Fauriat, N. Vey, 2012, Oncoimmunology.

Evolution of NK-mediated target recognition under the pressure of physiologic or pathologic stimuli

D. Olive, M. López-Botet, S. Sivori, 2015 .

Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2.

D. Olive, D. Blaise, P. Viens, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Cutting Edge: Recruitment of the Ancestral fyn Gene During Emergence of the Adaptive Immune System1

D. Olive, P. Pontarotti, A. Gilles, 2002, Journal of Immunology.

Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells

D. Olive, F. Orlanducci, N. Vey, 2023, Cells.

High-throughput mass cytometry staining for deep phenotyping of human natural killer cells

D. Olive, J. Nunès, N. Vey, 2022, STAR protocols.

Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients.

D. Olive, D. Blaise, P. Viens, 1999, Journal of immunotherapy.

Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2.

D. Olive, D. Blaise, H. Chambost, 1994, Leukemia.

The Molecular Basis for Modulation of Human V9V2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific

E. Adams, D. Olive, M. Bonneville, 2012 .

Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.

D. Olive, J. Reiffers, G. Marit, 1989, Bone marrow transplantation.

CD28 costimulation regulates long-term expression of the three genes (alpha, beta, gamma) encoding the high-affinity IL2 receptor.

F. Birg, D. Olive, C. Mawas, 1995, Research in immunology.

Reactivity of the Anti-Human T Cell Monoclonal Antibodies Submitted to the Workshop on One Anti-Class I and One Anti Class II Cytotoxic T Cell Clone

D. Olive, B. Malissen, C. Mawas, 1984 .

The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells

D. Olive, M. Bonneville, R. Breathnach, 2017, The Journal of Immunology.

Activation of Human V BTN 3 A 1 Controls Phosphoantigen-Mediated The Juxtamembrane Domain of Butyrophilin

D. Olive, M. Bonneville, R. Breathnach, 2017 .

An X-ray Vision for Phosphoantigen Recognition.

D. Olive, Michael Loran Dustin, E. Scotet, 2019, Immunity.

Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes.

D. Olive, J. Fournié, A. Savina, 2014, Immunology letters.

DOK4 and DOK5: new dok-related genes expressed in human T cells

D. Olive, P. Pontarotti, J. Nunès, 2003, Genes and Immunity.

Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody.

D. Olive, M. Cragg, M. Bi, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Tertiary lymphoid structures are associated with enhanced macrophage and dendritic cell activation and proximity to CD8+ T cells, which better predict the clinical outcome of cervical cancer patients

S. Granjeaud, D. Olive, M. Dieu-Nosjean, 2023, bioRxiv.

D. Olive, E. Béraud, D. Lombardo, 2012 .

Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patients.

D. Olive, J. Gabert, D. Blaise, 1991, European Cytokine Network.

Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression.

D. Olive, J. Imbert, H. Chambost, 1996, Journal of immunology.

316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A

D. Olive, J. Bono, N. Vey, 2020, Journal for ImmunoTherapy of Cancer.

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

D. Olive, J. D. Di Santo, L. Cifaldi, 2020, Frontiers in Immunology.

Profound and possibly primary "idiopathic CD4+ T lymphocytopenia" in a patient with fungal infections.

D. Olive, É. Oksenhendler, B. Autran, 1994, Clinical immunology and immunopathology.

Expression of Tac antigen in B cell lymphomas.

D. Olive, G. Delsol, G. Laurent, 1986, Clinical and Experimental Immunology.

Differential role for CD 277 as co-regulator of the immune signal in T and NK cells

B. Chetaille, D. Olive, J. Nunès, 2011 .

Therapeutic applications of anti-CD4 antibodies.

D. Olive, C. Mawas, 1993, Critical reviews in therapeutic drug carrier systems.